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The Colocalization of GABAB and CXCR4 in Medulloblastoma 
Philip Habashy, Dorota Lubanska, Lisa A. Porter, Huiming Zhang 
 
Medulloblastoma (MB) is the most common malignant pediatric brain tumor and it occurs in 16-25% of 
diagnosed cases, with a higher incidence in children aged 1 to 9 years old. The current standard of care 
consists of multiple stages of therapy including surgery, irradiation, and chemotherapy. However, a subset 
of tumors with a still devastating prognosis remains. 
Metabotropic receptors are G-protein coupled receptors (GPCRs) that act as second messengers. Γ-
aminobutyric acid B receptors (GABAB) and C-X-C chemokine receptor type 4 (CXCR4) are metabotropic 
receptors that belong to the C-family of GPCRs and are activated by the neurotransmitters, γ-
aminobutyrate (GABA) and stromal-cell derived factor; SDF-1 (CXCL12), respectively. GABAB receptors are 
heterodimers where GABA binds to a B1 subunit, and the B2 subunit is coupled to G-proteins regulating 
activities of the Ca2+ channels, K+ channels, and adenylyl cyclase (AC). 
Previous studies showed that CXCR4 is highly expressed by glial and neuronal cells in the central nervous 
system (CNS) and GABAergic neurons. Evidence shows that CXCR4 is overexpressed in MB and upon 
administration of a CXCR4 antagonist significantly decreased the cell proliferation rate in Type II MB. 
Evidence also proved that CXCR4 and GABAB can crosstalk and GABAB was found to be highly expressed 
in Type II – MB showing increased Ca2+ levels and protein receptor localization. Current results show that 
upon administration of the GABAB agonist; baclofen increased cell proliferation in Type II MB cells. 
Moreover, immunofluorescence showed increased levels of GABAB during mitotic division. In conclusion, 
by administering the antagonist; phaclofen would enhance the efficacy of chemotherapeutic treatments 
on MB patients by decreasing the proliferation rate of the aggressive tumors. 
